In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them

Journal of Cellular Physiology

Volumn 214, Issue 3, 2008, Pages 588-594

  Suva, Domizio ^a   Passweg, Jakob ^a   Arnaudeau, Serge ^b   Hoffmeyer, Pierre ^a   Kindler, Vincent ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; GAMMA INTERFERON ANTIBODY; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD28; PHYTOHEMAGGLUTININ; TRYPTOPHAN; CD3 ANTIGEN; GAMMA INTERFERON;

ARTICLE; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LYMPHOCYTE MIGRATION; MESENCHYME CELL; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MESODERM; METABOLISM; MULTIPOTENT STEM CELL; PHENOTYPE; T LYMPHOCYTE; THROMBOCYTE;

ANTIGENS, CD3; BLOOD PLATELETS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MESODERM; MULTIPOTENT STEM CELLS; PHENOTYPE; STROMAL CELLS; T-LYMPHOCYTES;

EID: 38449114611     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21244     Document Type: Article

References (32)

1. Baban B, Chandler P, McCool D, Marshall B, Munn DH, Mellor AL. 2004. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 61:67-77.
2. Blankenstein T. 2005. The role of tumor stroma in the interaction between tumor and immune system. Curr Opin Immunol 17:180-186.
3. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843.
4. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D, Jorgensen C. 2003. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837-3844.
5. Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noel D. 2005. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 52:1595-1603.
6. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, Lataillade JJ. 2005. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205:228-236.
7. Friedenstein AJ. 1961. Osteogenetic activity of transplanted transitional epithelium. Acta Anat (Basel) 45:3 1-59.
8. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. 2005. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393-395.
9. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
10. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F. 2005. Rolefor IFN-{gamma} in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells
11. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F. 2006. Role for interferon-gam ma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386-398.
12. Le Blanc K, Ringden O. 2005. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:321-334.
13. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O. 2003. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57:11-20.
14. Le Blanc K, Rasmusson I, Gotherstrom C, Seidel C, Sundberg B, Sundin M, Rosendahl K, Tammik C, Ringden O. 2004a. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin- activated lymphocytes. Scand J Immunol 60:307-315.
15. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O. 2004b. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441.
16. Lipsky PE, Ellner JJ, Rosenthal AL. 1976. Phytohemagglutinin-induced proliferation of guinea pig thymus-derived lymphocytes. I. Accessory cell dependence. J Immunol 116:868-875.
17. Lyons AB, Parish CR. 1994. Determination of lymphocyte division by flow cytometry. J Immunol Methods 171:131-137.
18. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. 1998. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415-428.
19. Majumdar MK, Keane-Moore M, Buyaner D, Hardy WB, Moorman MA, McIntosh KR, Mosca JD. 2003. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10:228-241.
20. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D, 2004. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621.
21. Modiano JF, Mayor J, Ball C, Chitko-McKown CG, Sakata N, Domenico-Hahn J, Lucas JJ, Gelfand EW. 1999. Quantitative and qualitative signals determine T-cell cycle entry and progression. Cell Immunol 197:19-29.
22. Muller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A, Viebahn S, Gieseke F, Langer H, Gawaz MP, Horwitz EM, Conte P, Handgretinger R, Dominici M. 2006. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8:437-444.
23. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363-1372.
24. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
25. Ploemacher RE, van der Sluijs JP, Voerman JS, Brons NH. 1989. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74:2755-2763.
26. Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC, Favrot MC. 2005. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 19:1597-1604.
27. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. 2006. Mesenchymal stem cells for treatment of therapy-res is tant graft-versus-host disease. Transplantation 81:1390-1397.
28. Schmid I, Uittenbogaart CH, Keld B, Giorgi JV. 1994. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 170:145-157.
29. Suva D, Garavaglia G, Menetrey J, Chapuis B, Hoffmeyer P, Bernheim L, Kindler V. 2004. Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. J Cell Physiol 198:110-118.
30. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. 2003. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 75:389-397.
31. Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ. 2003. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269-1274.
32. Yu P, Rowley DA, Fu YX, Schreiber H. 2006. The role of stroma in immune recognition and destruction of well-established solid tumors. Curr Opin Immunol 18:226-231.